José Medina‐Pestana

Belatacept-Based Regimens Are Associated With Improved Cardiovascular and Metabolic Risk Factors Compared With Cyclosporine in Kidney Transplant Recipients (BENEFIT and BENEFIT-EXT Studies)

Yves Vanrenterghem, Barbara A. Bresnahan, Josep M. Campistol et al. · Transplantation · 2011 · 179 citations

Long-Term Outcomes in Belatacept- Versus Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT-EXT, a Phase III Randomized Study

Antoine Dürrbach, José Medina‐Pestana, Sander Florman et al. · American Journal of Transplantation · 2016 · 152 citations · Full text

An Integrated Safety Profile Analysis of Belatacept in Kidney Transplant Recipients

Josep M. Grinyó, Bernard Charpentier, José Medina‐Pestana et al. · Transplantation · 2010 · 123 citations

Comparison of 30-day case-fatality rate between dialysis and transplant Covid-19 patients: a propensity score matched cohort study

Tainá Veras de Sandes‐Freitas, Luís Gustavo Modelli de Andrade, Lúcio Requião‐Moura et al. · Journal of Nephrology · 2021 · 92 citations · Full text

High mortality among kidney transplant recipients diagnosed with coronavirus disease 2019: Results from the Brazilian multicenter cohort study

Lúcio Requião‐Moura, Tainá Veras de Sandes‐Freitas, Laila Almeida Viana et al. · PLoS ONE · 2021 · 83 citations · Full text